melanoma

pendulum silver metallic spheres on coloured background with drop shadow
Biotech

As investors pivot from cell therapy, Immatics keeps the faith

The biotech is planning for a potential commercial launch in the third quarter of 2027, a market debut Immatics intends to fund on its own.
Gabrielle Masson Jun 6, 2025 3:50am
pile of cash piggy bank money cash dollars bills spend

Pathos AI's $365M series D to fund trial of Novo tumor drug

May 15, 2025 10:20am
An open book with pages turning on a wooden table set

Erasca looks to partner off late-stage melanoma asset

May 13, 2025 10:38am
frog leapfrog jump climb over

Immatics leaps into phase 3 on strength of early-stage PFS data

Oct 10, 2024 8:49am
predictive analytics

Black Diamond, Ideaya mull registrational trials for cancer meds

Sep 23, 2024 12:18pm
Businessman jumping over hurdle - stock photo viafilmsGetty Images

BioNTech, Regeneron rack up response rate win for cancer vaccine

Jul 30, 2024 6:45am